-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q3 2023 to Q4 2024.
- Neuphoria Therapeutics Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending December 31, 2024 was -$3.23M, a 21.2% increase year-over-year.
- Neuphoria Therapeutics Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2024 was -$15.4M, a 31.1% increase from 2023.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)